Doctor in Molecular Pharmacology, with more than 25 years' experience in Drug Discovery and Development of innovative drugs in the R&D area of the pharmaceutical and biotech industry: • Dolors has participated in many drug developments of new chemical molecules, oligonucleotides and recombinant proteins for human and canine therapy and prophylaxis in diverse therapeutic areas, with several new drugs in the market. • She has conducted preclinical and clinical studies in molecular and cell biology, pharmacology, safety and toxicology, DMPK and biomarker development under GSP, GLP and GCP. • She has leaded projects, laboratories, teams, expert panels and academic research. • She is involved in the documentation management for regulatory agencies, with several dossiers approved, either for clinical trials and marketing authorization. • Dolors has published peer-reviewed papers, book chapters, communications to congresses and patents. • She is used in the management of public funding, either at local or European level. • She is External Expert Evaluator in health projects for the European Commission and AGAUR, provides advice to biotech companies, and teaches at master programmes at University. • She is very used to collaborating closely with all areas involved in drug development at international level. Dolors brings a translational vision in drug development, integrating data from the different preclinical areas into clinical trials and dossier submission for marketing approval.